StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lipella Pharmaceuticals's enterprise value was -$1.85M on Oct 19, 2026, against -$838.51K a year earlier. Over the last 4 years it ranged from -$2.44M to $10.39M, with a median of $1.60M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026-$1.85M–
2025Dec 31, 2025-$1.02M-151.9%
2024Dec 31, 2024$1.97M-43.8%
2023Dec 29, 2023$3.51M-66.2%
2022Dec 30, 2022$10.39M–

More Lipella Pharmaceuticals figures

See a number that looks wrong?